Mutual Fund Details
NAV
₹27.9200
as on 10 Jul 2025, 09:00 PM
₹-0.1300(0.46%)
Last Change
Scheme Ratings
5
rated by Value Research
Pharma
Rankings based on | as on Invalid date
×
Schemes Managed By
Download the Paytm Money app now!
Invest in Stocks, F&O, Mutual Funds, IPOs, NFOS and Bonds.
Zero brokerage for 30 days- Zero account opening fees
- Zero AMC for life
Scan QR code to download the app
Investment Performance
would have given a return of
₹1,10,871
₹1,21,647
₹2,15,791
₹2,21,495
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹1,21,495
Profit (absolute return)
121.50%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 3 months
15.79%
In the last 6 months
1.54%
In the last 1 year
19.06%
In the last 3 years
121.50%
In the last 5 years
215.03%
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
low to moderate
moderate
moderately high
high
very high
Investors understand that their principal will be at very high risk
Scheme Information
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct-IDCW
as of 30 Jun 2025, 05:30 AM
₹5,727.59 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 15 days.
1.05%
Expense Ratio
Plan
Dividend
Benchmark
BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 15 days.
Scheme Document
Sectors Holding in this Mutual Fund
as on 30 Jun 2025
Healthcare
89.23%
₹5,110.44 Cr
Chemicals
3.69%
₹211.46 Cr
Services
2.80%
₹160.35 Cr
Insurance
1.27%
₹72.81 Cr
Others
3.01%
₹172.40 Cr
Companies Holding in this Mutual Fund
as on 30 Jun 2025
Sun Pharmaceutical Industries Ltd.
12.66%
₹725.11 Cr
Dr. Reddy's Laboratories Ltd.
9.66%
₹553.28 Cr
Divi's Laboratories Ltd.
9.03%
₹517.20 Cr
Cipla Ltd.
7.85%
₹449.62 Cr
Aurobindo Pharma Ltd.
6.34%
₹363.13 Cr
Others
54.46%
₹3,119.24 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 30 Jun 2025
Sun Pharmaceutical Industries Ltd.
12.66%
₹725.11 Cr
Dr. Reddy's Laboratories Ltd.
9.66%
₹553.28 Cr
Divi's Laboratories Ltd.
9.03%
₹517.20 Cr
Cipla Ltd.
7.85%
₹449.62 Cr
Aurobindo Pharma Ltd.
6.34%
₹363.13 Cr
Others
54.46%
₹3,119.24 Cr
View All
View All
This fund's returns:
30.29%Return Duration
3 Years
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
19.55%
30.29%
3Y Returns
30.29
SBI Healthcare Opportunities Fund Direct Plan-Growth
EquityPharma
Min. Investment
₹500
Category Returns
19.55%
30.29%
3Y Returns
29.93
UTI Healthcare Fund Direct-Growth
EquityPharma
Min. Investment
₹500
Category Returns
19.55%
30.29%
3Y Returns
27.49
About ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct-IDCW
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct-IDCW is a Equity mutual fund scheme from ICICI Prudential Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund manager Dharmesh Kakkad. It has an AUM of ₹5,727.59 Crores and the latest NAV decalared is ₹27.920 as on 11 Jul 2025 at 5:05 am.
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct-IDCW scheme return performance in last 1 year is 19.06%, in last 3 years is 121.50% and 332.44% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.
Scheme Details
| AUM: | ₹5,727.59 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | Invalid date |
| Fund Type: | Open-End |
AMC Information
ICICI Prudential Mutual Fund
View AMC Details
₹9,56,306.15 Cr
AUM
290
Schemes
Address
One BKC , A Wing ,13th Floor, Bandra Kurla Complex,400051
Phone Number
Fax : 022-26528100
Email / Website
Start investing in minutes
Download app to Explore
Scan this QR code to download the app now!
Or download from
